UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

02.35 Time of flight mass cytometry (cytof) and rna sequencing interrogation of ‘pathogenic’ gm-csf lymphocytes in human spondyloarthritis

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A22

2017

Volltextzugriff (PDF)

02.35Time of flight mass cytometry (cytof) and rna sequencing interrogation of 'pathogenic' gm-csf lymphocytes in human spondyloarthritis

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A22-A23

2017

Volltextzugriff (PDF)

03.20 Identification of chromatin modifying mechanisms in inflammatory macrophages in rheumatoid arthritis

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A38

2017

Volltextzugriff (PDF)

03.20Identification of chromatin modifying mechanisms in inflammatory macrophages in rheumatoid arthritis

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A38-A38

2017

Volltextzugriff (PDF)

1502 Lupus low disease activity state attainment in the phase 3 placebo-controlled TULIP long-term extension trial of anifrolumab

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A114-A115

2024

Volltextzugriff (PDF)

197Increased CD4 T Cell Granulocyte-Macrophage Colony-Stimulating Factor Production in Spondyloarthritis

Rheumatology (Oxford, England), 2016-04, Vol.55 (suppl_1), p.i142-i142

2016

Volltextzugriff (PDF)

234. KIR3DL2 Binding to HLA-B27 Licences Pathogenic T-Cell Differentiation in Spondyloarthritis

Rheumatology (Oxford, England), 2014-04, Vol.53 (suppl_1), p.i147-i148

2014

Volltextzugriff (PDF)

Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.901-914

2016

Volltextzugriff (PDF)

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (34), p.10768-10773

2015

Volltextzugriff (PDF)

Characterization of the genetic determinants of context-specific DNA methylation in primary monocytes

Cell genomics, 2024-05, Vol.4 (5), p.100541-100541, Article 100541

2024

Volltextzugriff (PDF)

Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor

Bioengineered, 2024-12, Vol.15 (1), p.2299522-2299522

2024

Volltextzugriff (PDF)

The Clinical Role of Glucocorticoids in the Management of Rheumatoid Arthritis

Al-Mossawi, Hussein

2012

Volltextzugriff (PDF)

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele

Nature communications, 2019-10, Vol.10 (1), p.4575-11, Article 4575

2019

Volltextzugriff (PDF)

Correction: Targeting DORIS Remission and LLDAS in SLE: A Review

Rheumatology and therapy., 2024-08, Vol.11 (4), p.1059-1061

2024

Volltextzugriff (PDF)

Development and implementation of 'A guide to PPIE - Early Integration into Research Proposals' in a multi-disciplinary consortium

Rheumatology (Oxford, England), 2024-03, Vol.63 (3), p.e88-e91

2024

Volltextzugriff (PDF)

Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease

Journal of allergy and clinical immunology, 2023-09, Vol.152 (3), p.783-798

2023

Volltextzugriff (PDF)

Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid

Annals of the rheumatic diseases, 2021-12, Vol.80 (12), p.1559-1567

2021

Volltextzugriff (PDF)

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply

Annals of the rheumatic diseases, 2014-04, Vol.73 (4), p.763-770

2014

Volltextzugriff (PDF)

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet. Rheumatology, 2024-08, Vol.6 (8), p.e537-e545

2024

Volltextzugriff (PDF)

The immunology underlying rheumatic diseases

The Biomedical & Life Sciences Collection, 2021-12, Vol.2021 (12), p.e1005153

Al-Mossawi, Hussein

2021

Volltextzugriff (PDF)

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases

Scientific reports, 2018-10, Vol.8 (1), p.15645-8, Article 15645

2018

Volltextzugriff (PDF)

LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A169-A170

2024

Volltextzugriff (PDF)

The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis

Modern rheumatology, 2024-07, Vol.34 (4), p.720-731

2024

Volltextzugriff (PDF)

Multi-omic single cell analysis resolves novel stromal cell populations in healthy and diseased human tendon

Scientific reports, 2020-09, Vol.10 (1), p.13939-13939, Article 13939

2020

Volltextzugriff (PDF)

Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology

Annals of the rheumatic diseases, 2021-12, Vol.80 (12), p.1505-1510

2021

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

02.35 Time of flight mass cytometry (cytof) and rna sequencing interrogation of ‘pathogenic’ gm-csf lymphocytes in human spondyloarthritis

02.35Time of flight mass cytometry (cytof) and rna sequencing interrogation of 'pathogenic' gm-csf lymphocytes in human spondyloarthritis

03.20 Identification of chromatin modifying mechanisms in inflammatory macrophages in rheumatoid arthritis

03.20Identification of chromatin modifying mechanisms in inflammatory macrophages in rheumatoid arthritis

1502 Lupus low disease activity state attainment in the phase 3 placebo-controlled TULIP long-term extension trial of anifrolumab

197Increased CD4 T Cell Granulocyte-Macrophage Colony-Stimulating Factor Production in Spondyloarthritis

234. KIR3DL2 Binding to HLA-B27 Licences Pathogenic T-Cell Differentiation in Spondyloarthritis

Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Characterization of the genetic determinants of context-specific DNA methylation in primary monocytes

Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor

The Clinical Role of Glucocorticoids in the Management of Rheumatoid Arthritis

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele

Correction: Targeting DORIS Remission and LLDAS in SLE: A Review

Development and implementation of 'A guide to PPIE - Early Integration into Research Proposals' in a multi-disciplinary consortium

Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease

Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

The immunology underlying rheumatic diseases

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases

LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis

The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis

Multi-omic single cell analysis resolves novel stromal cell populations in healthy and diseased human tendon

Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology

Suchergebnisse filtern